Daniel A Pollyea
Affiliation: Stanford University
- Utility of influenza vaccination for oncology patientsDaniel A Pollyea
Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA
J Clin Oncol 28:2481-90. 2010....
- Acute myeloid leukaemia in the elderly: a reviewDaniel A Pollyea
Divisions of Hematology and Oncology, Department of Internal Medicine, University Cancer Center, Stanford University School of Medicine, 875 Blake Wilbur Drive, Stanford, CA 94305, USA
Br J Haematol 152:524-42. 2011..Elderly patients, with their narrow therapeutic window, are well positioned to derive a benefit from these novel agents, and therefore, despite a difficult past, there are reasons to be optimistic about the future of elderly AML...
- Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemiaDaniel A Pollyea
Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA
Haematologica 98:591-6. 2013..In conclusion, a sequential combination of azacitidine plus lenalidomide has clinical activity in older patients with acute myeloid leukemia, and further studies of this combination are underway...
- Second-line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: a single-center experienceHolbrook E Kohrt
Department of Medicine, Division of Hematology, Stanford University, Stanford, CA 94305, USA
Am J Hematol 85:877-81. 2010..3 and 7.6 months, P = 0.36). Despite risk stratification by the European Prognostic Index, our series demonstrates inferior rates of response and survival, illustrating the limited activity of this regimen in our cohort...